Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

RHHBY Relative to the S&P 500

RHHBY Relative to the Sector

Seasonal Chart Analysis

Analysis of the Roche Holding Ltd. (OTCMKT:RHHBY) seasonal charts above shows that a Buy Date of November 30 and a Sell Date of February 21 has resulted in a geometric average return of 0.5% above the benchmark rate of the S&P 500 Total Return Index over the past 12 years. This seasonal timeframe has shown positive results compared to the benchmark in 9 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 12 years by an average of 5.77% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Roche is a Swiss biopharmaceutical and diagnostic company. The firm’s best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 60% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

To download RHHBY seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: RHHBY